News from signum dermalogix, inc

Nov 14, 2013, 11:10 ET

Signum Dermalogix Receives $1.6M Phase II SBIR Grant for the Development of Novel Atopic Dermatitis Therapeutics

 Signum Dermalogix, Inc. ("Dermalogix") announced today that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)...

Jul 08, 2013, 12:35 ET

Signum Dermalogix Investigational New Drug (IND) Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea

 Signum Dermalogix, Inc. ("Dermalogix") a private biopharmaceutical company focused on developing new and innovative dermatological...

Feb 26, 2013, 10:45 ET

Signum Dermalogix Partners with Elizabeth Arden, Launches Product Containing Cosmetic Functional Ingredient Arazine™

Signum Dermalogix Inc., a private biopharmaceutical company focused on developing new and innovative dermatological products and services has...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge